Publications

2016

Trasino SE, Tang X-, Jessurun J, Gudas LJ. A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease. J Mol Med (Berl). 2016;94(10):1143-1151.
Yuan Z, Claros CS, Suzuki M, Maggi EC, Kaner JD, Kinstlinger N, et al. Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis. Oncotarget. 2016;7(11):12633-50.
Moscat J, Karin M, Diaz-Meco MT. p62 in Cancer: Signaling Adaptor Beyond Autophagy. Cell. 2016;167(3):606-609.
Inayat F, Law JK, Myers-Gurevitch PM, Seshan SV, Perlman AS. Minimal change disease: an unusual presentation of marginal zone MALT lymphoma. Clin Nephrol. 2016;85(3):184-8.
Serra S, Vaisitti T, Audrito V, Bologna C, Buonincontri R, Chen S-, et al. Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment. Blood Adv. 2016;1(1):47-61.
Santo EE, Paik J. FOXO3a & haematopoietic stem cells: Goodbye PI3K, hello SIRT1? Cell Cycle. 2016;15(7):879-80.
Chia JJ, Zhu T, Chyou S, Dasoveanu DC, Carballo C, Tian S, et al. Dendritic cells maintain dermal adipose-derived stromal cells in skin fibrosis. J Clin Invest. 2016;126(11):4331-4345.
Khani F, Diolombi ML, Khattar P, Huang W, Fallon JT, Epstein JI, et al. Benign and Malignant Brenner Tumors Show an Absence of TERT Promoter Mutations That Are Commonly Present in Urothelial Carcinoma. Am J Surg Pathol. 2016;40(9):1291-5.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700